|
|
|
|
| |
|
| |
|
|
https://mb.cision.com/Public/18595/logo/86a99b25f755738d_org.jpg
UCB Announces European Commission Approval of BIMZELX^=C2=AE=E2=96=BC b=
imekizumab for the Treatment of Adults with Moderate to Severe Plaque Psor=
iasis
=C2=B7 BIMZELX^=C2=AE=E2=96=BCbimekizumab is the first approved treatment=
for moderate to severe plaque psoriasis that is designed to selectively an=
d directly... See more |
|
|
|
| |
|
| |
|
|
https://mb.cision.com/Public/18595/logo/86a99b25f755738d_org.jpg
Disposals of own shares
Brussels Belgium, 20 August 2021 =E2=80=93 20:00 CEST =E2=80=93 regulat=
ed information
Disposal of own shares
In accordance with article 8:6 of the Royal Decree executing the Belgian Co=
de of Companies and Associations, UCB=C2=A0announces that, following exerci=
ses of stock options by... See more |
|
|
|
| |
|
| |
|
|
|
|
| |
|
| |
|
|
https://mb.cision.com/Public/18595/logo/86a99b25f755738d_org.jpg
Disposals of own shares
Brussels Belgium, 13 August 2021 =E2=80=93 20:00 CEST =E2=80=93 regulat=
ed information
Disposal of own shares
In accordance with article 8:6 of the Royal Decree executing the Belgian Co=
de of Companies and Associations, UCB=C2=A0announces that, following exerci=
ses of stock options by... See more |
|
|
|
| |
|
| |
|
|
|
|
| |
|
| |
|
|
https://mb.cision.com/Public/18595/logo/86a99b25f755738d_org.jpg
Transparency notification FMR LLC.
=C2=B7 Notification referring to situation on 30 July 2021
=C2=B7 Threshold crossed: 5%
=C2=B7 Latest holding: 3.63 %
Brussels Belgium, 9 August 2021 =E2=80=93 20:00 CEST =E2=80=93 regulate=
d information
1. Summary of the notification
Pursuant to Article 14 of the law of 2 May... See more | |
Search :
